Skip to main content

Research Demonstrates Superior Resolution for Kavalactone Standards

This scientific application note focuses on the analysis of 9 Kavalactones using a high-performance liquid chromatography (HPLC) method. Kavalactones are naturally occurring compounds found in the roots of the kava plant. This application highlights the use of the YMC-Triart C8 column and its superior resolution compared to traditional C18 stationary phases, allowing for the clear separation of these compounds. The research demonstrates the effectiveness of the method for analyzing Kavalactones in both standard solutions and commercial kava formulations.

See the Application Note.

Posted on November 11, 2024.

Related Posts

September 21, 2026

Join us for our upcoming webinar titled Peptide Purification: From HPLC Origins to Process Intensification

This presentation explores the evolution of peptide purification, from the early days of reversed-phase HPLC to today’s large-scale manufacturing challenges. It covers practical strategies for preparative method development, stationary phase selection, and efficient scale-up, illustrated by a case study on tirzepatide purification. The session also introduces continuous chromatography using MCSGP technology and highlights its potential for process intensification in modern peptide manufacturing.

September 4, 2026

YMC America Brings U.S.-Supplied ASME U-Stamped DAC Columns to Pharmaceutical Manufacturers

YMC America will be the First U.S.-Based Supplier of ASME U-Stamped DAC Columns. The company’s DAC columns support pharmaceutical and biopharmaceutical customers from process development through commercial production. Systems are used in laboratory, pilot, and production-scale chromatography applications, including purification processes for peptides, oligonucleotides, and small-molecule APIs.

September 10, 2026

Analytical Technologies for Therapeutic Peptides

Therapeutic peptides are an emerging class of active pharmaceutical ingredients that, together with other classes of bioproducts, have been attracting considerable attention due to their unique advantages. Their structure is based on well-defined amino acid sequences that may or may not contain structural modifications, resulting in molecules that generally range from 500 to 5000 Da. Currently, many examples can be used as medicines related to hormones, growth factors, neurotransmitters, among others.

Designed and developed by